Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Buy
2,037
+11
+0.5% +$3.77K 0.19% 41
2026
Q1
$713K Buy
2,026
+10
+0.5% +$3.56K 0.21% 42
2025
Q4
$660K Buy
2,016
+12
+0.6% +$3.81K 0.2% 44
2025
Q3
$566K Buy
2,004
+12
+0.6% +$3.48K 0.18% 48
2025
Q2
$556K Buy
1,992
+12
+0.6% +$3.4K 0.18% 49
2025
Q1
$617K Buy
1,980
+11
+0.6% +$3.25K 0.22% 41
2024
Q4
$513K Hold
1,969
0.19% 46
2024
Q3
$634K Hold
1,969
0.23% 42
2024
Q2
$615K Hold
1,969
0.23% 39
2024
Q1
$560K Hold
1,969
0.22% 45
2023
Q4
$567K Hold
1,969
0.25% 40
2023
Q3
$524K Hold
1,969
0.33% 34
2023
Q2
$437K Hold
1,969
0.23% 53
2023
Q1
$476K Hold
1,969
0.25% 49
2022
Q4
$444K Hold
1,969
0.29% 43
2022
Q3
$444K Hold
1,969
0.29% 43
2022
Q2
$484K Hold
1,969
0.29% 41
2022
Q1
$482K Hold
1,969
0.23% 52
2021
Q4
$443K Hold
1,969
0.2% 54
2021
Q3
$419K Hold
1,969
0.22% 53
2021
Q2
$480K Hold
1,969
0.25% 49
2021
Q1
$490K Hold
1,969
0.28% 41
2020
Q4
$453K Buy
1,969
+300
+18% +$69.2K 0.27% 42
2020
Q3
$424K Buy
1,669
+100
+6% +$24.8K 0.3% 40
2020
Q2
$397K Hold
1,569
0.33% 39
2020
Q1
$318K Hold
1,569
0.33% 42
2019
Q4
$357K Buy
+1,569
New +$346K 0.26% 42

Other funds holding AMGN

360 Financial's AMGN Position: Q2 2026 in Review

360 Financial increased its Amgen (AMGN) stake by 0.54% in Q2 2026, buying an estimated $3.77K and bringing the position to 2,037 shares worth $738K. The position accounts for 0.19% of the portfolio, ranked #41.

360 Financial first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • 360 Financial held 2,037 shares of Amgen worth $738K as of Q2 2026.
  • 360 Financial bought 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.19% of 360 Financial's portfolio in Q2 2026, its #41 holding.
  • 360 Financial first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 360 Financial's 13F filing for Q2 2026, filed 11 Aug 2026.